Markets › India › NSE › GLENMARK

Glenmark Pharmaceuticals Ltd

NSE:GLENMARKHealthcareNSE:CNX200NSE:CNX500

₹2,210.20−0.74%At closeAt close · Mon 19 Oct · ≈ AED 85.28 · Market cap $6.62B · Next earnings Fri 6 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	64.8%	63.0%	62.2%	63.8%	66.1%	47.6%	—	—
Operating margin	27.1%	28.9%	24.1%	26.8%	31.3%	23.5%	23.5%	+0.0 pts
Net margin	8.9%	7.7%	2.6%	−11.9%	7.8%	8.0%	8.0%	+0.0 pts
EBITDA margin	17.8%	15.5%	12.3%	14.5%	16.2%	16.3%	—	—
Return on equity	13.7%	10.4%	3.1%	−19.1%	11.8%	13.0%	13.0%	+0.0 pts
Return on assets	6.2%	5.5%	1.5%	−10.5%	6.5%	6.8%	6.8%	+0.0 pts
Return on capital employed	26.0%	28.7%	19.7%	39.7%	41.5%	29.6%	—	—
Debt / equity	0.7×	0.4×	0.5×	0.2×	0.3×	0.1×	0.1×	+0.0%
Debt / assets	32.0%	23.2%	23.8%	8.6%	15.4%	3.0%	—	—
Interest coverage	8.4×	11.9×	8.1×	6.6×	20.2×	19.2×	—	—
Current ratio	1.8×	1.8×	2.1×	1.3×	1.6×	1.8×	1.8×	+0.0%
Quick ratio	1.2×	1.2×	1.6×	0.8×	1.0×	1.2×	—	—
Cash ratio	0.3×	0.3×	0.2×	0.3×	0.3×	0.2×	0.2×	+0.0%
Asset turnover	0.7×	0.7×	0.6×	0.9×	0.8×	0.9×	—	—
Inventory turnover	1.7×	1.8×	1.9×	1.8×	1.4×	2.6×	—	—
Receivables turnover	4.3×	4.0×	3.6×	6.8×	3.2×	3.4×	—	—
Dividend payout	7.3%	9.8%	46.0%	−7.8%	6.7%	10.4%	—	—